132 related articles for article (PubMed ID: 21440745)
1. Hematologic side effects of azathioprine and mycophenolate in kidney transplantation.
Habas E; Khammaj A; Rayani A
Transplant Proc; 2011 Mar; 43(2):504-6. PubMed ID: 21440745
[TBL] [Abstract][Full Text] [Related]
2. Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients.
Khosroshahi HT; Asghari A; Estakhr R; Baiaz B; Ardalan MR; Shoja MM
Transplant Proc; 2006 Sep; 38(7):2077-9. PubMed ID: 16980004
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
[TBL] [Abstract][Full Text] [Related]
5. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.
Bernabeu-Wittel M; Naranjo M; Cisneros JM; Cañas E; Gentil MA; Algarra G; Pereira P; González-Roncero FJ; de Alarcón A; Pachón J
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):173-80. PubMed ID: 11957018
[TBL] [Abstract][Full Text] [Related]
6. Low-dose sirolimus in combination with mycophenolate mofetil improves kidney graft function late after renal transplantation and suggests pharmacokinetic interaction of both immunosuppressive drugs.
Renders L; Steinbach R; Valerius T; Schöcklmann HO; Kunzendorf U
Kidney Blood Press Res; 2004; 27(3):181-5. PubMed ID: 15256815
[TBL] [Abstract][Full Text] [Related]
7. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
Basic-Jukic N; Kes P; Bubic-Filipi LJ; Puretic Z; Brunetta B; Pasini J
Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
Ducloux D; Motte G; Billerey C; Bresson-Vautrin C; Vautrin P; Rebibou JM; Saint-Hillier Y; Chalopin JM
Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
[TBL] [Abstract][Full Text] [Related]
10. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
Rivinius R; Helmschrott M; Ruhparwar A; Schmack B; Klein B; Erbel C; Gleissner CA; Akhavanpoor M; Frankenstein L; Darche FF; Thomas D; Ehlermann P; Bruckner T; Katus HA; Doesch AO
Drug Des Devel Ther; 2015; 9():93-102. PubMed ID: 25552900
[TBL] [Abstract][Full Text] [Related]
11. Comparison of transplanted kidney function in patients on two different doses of mycophenolate mofetil.
Khosroshahi HT; Nahali A; Gojazadeh M; Shoja MM
Transplant Proc; 2006 Sep; 38(7):2035-7. PubMed ID: 16979991
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil dose reduction in renal transplant recipients: a 5-year follow-up study.
Khosroshahi HT; Shoja MM; Peyrovifar A; Hashemi SR; Amjadi M
Transplant Proc; 2009 Sep; 41(7):2797-9. PubMed ID: 19765438
[TBL] [Abstract][Full Text] [Related]
13. Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients?
Prokopenko E; Scherbakova E; Vatazin A; Pasov S; Budnikova N; Agafonova S
Drugs Exp Clin Res; 2005; 31(5-6):199-205. PubMed ID: 16425976
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
Dooley MA; Jayne D; Ginzler EM; Isenberg D; Olsen NJ; Wofsy D; Eitner F; Appel GB; Contreras G; Lisk L; Solomons N;
N Engl J Med; 2011 Nov; 365(20):1886-95. PubMed ID: 22087680
[TBL] [Abstract][Full Text] [Related]
16. Side effects of mycophenolate mofetil versus azathioprine in iranian renal transplant recipients (single-center experience).
Hakemi M; Shahebrahimi K; Ganji MR; Najafi I; Broumand B
Transplant Proc; 2002 Sep; 34(6):2091-2. PubMed ID: 12270326
[No Abstract] [Full Text] [Related]
17. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
Bakr MA; Gheith OA; Ismael AM; Baz ME; Shehab El-Dein AB; Ghoneim MA
Exp Clin Transplant; 2008 Mar; 6(1):48-53. PubMed ID: 18405245
[TBL] [Abstract][Full Text] [Related]
18. Conversion from azathioprine to mycophenolate mofetil followed by calcineurin inhibitor minimization or elimination in patients with chronic allograft dysfunction.
Garcia R; Pinheiro-Machado PG; Felipe CR; Park SI; Silva LA; Franco MF; Tedesco-Silva H; Medina-Pestana JO
Transplant Proc; 2006 Nov; 38(9):2872-8. PubMed ID: 17112853
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of azathioprine versus mycophenolate mofetil in cyclosporine-based immunosuppression in kidney transplantation: 10 years of experience at a single center.
Kwon O; Cho JH; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transplant Proc; 2013 May; 45(4):1487-90. PubMed ID: 23726603
[TBL] [Abstract][Full Text] [Related]
20. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]